• Profile
Close

Glutathione infusion before primary percutaneous coronary intervention: A randomized controlled pilot study

BMJ Open Aug 15, 2019

Tanzilli G, Truscelli G, Arrivi A, et al. - Fifty consecutive individuals with ST-elevation myocardial infarction who were scheduled to undergo primary angioplasty were recruited in this study to see if the infusion of glutathione (GSH) prior to acute reoxygenation could counteract the harmful influences of higher H2O2 generation on myocardium. In comparison with placebo, a significant decrease of H2O2 production and 8-iso-PGF2α levels and a significant rise in H2O2 breakdown activity and nitric oxide bioavailability was discovered in the GSH group after acute reperfusion. Reduced production of H2O2 continued up to 5 days after the index procedure in treated individuals, and these variations were connected to those of the cardiactroponin T levels. The infusion of GSH appeared to trigger a rapid onset and persistent blunting of H2O2 generation enhancing myocardial cell survival.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay